Presentations, Posters & Abstracts
Investigators of the Add-Aspirin study regularly disseminate status updates and results from the study at conferences in the form of presentations and posters. Please find below a list of these presentations and posters.
- 2020: Embedding survivorship studies in an ongoing trial: Adding value to Add-Aspirin. UK Interdisciplinary Breast Cancer Symposium
- 2019: Use of an active run-in period in a cancer trial: The Add-Aspirin experience. International Clinical Trials Methodology Conference
- 2019: Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial. ASCO
- 2018: Aspirin use after radical cancer therapy – feasibility and toxicity data from the Add-Aspirin trial. NCRI Conference
- 2018: The Role of Aspirin Following Treatment for Early Stage Gastro-Oesophageal Cancer: Adherence and Tolerability Data from the Add-Aspirin Trial. AUGIS
- 2017: Co-enrolment of participants into multiple clinical trials: The Add-Aspirin trial experience. NCRI Conference
News and Resources
Contact Details
If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.
For healthcare professionals
Please log into the members area for Add-Aspirin contact details.
Register Interest
For healthcare professionals
If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk
From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK